Pila Pharma AB at the Annual General Meeting held on April 18, 2024 announced its founder and Director of the Board, Dorte X. Gram was elected new Chairman of the Board with immediate effect. The newly elected Board of Directors has subsequently appointed Dorte X. Gram as Chief Scientific Officer (CSO) of Pila Pharma AB. Further two new members have been elected to strengthen the Boards financial, strategic and market insight, thus recalibrating the objectives of Pila Pharma AB.

Lasse Richter Petersen has been elected Director of the Board due to his extensive background and experience in the international pharmaceutical business including diabetes, and Julie Waras Brogren has been elected Director of the Board due to her extensive experience in developing strategies for advancing pharma assets from development to commercialisation and in finance and investor relations.